Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Locarnini

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Bulletin of the World Health Organization|April 30, 2010
Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?C John Clements, Ben Coghlan, Mick Creati, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2007
The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitroNadia Warner, Stephen Locarnini, Michael Kuiper, et al.
Antiviral Research|December 6, 2011
Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunitsWan-Shoo Cheong, Michiko Hyakumura, Lilly Yuen, et al.
Hepatology (Baltimore, Md.)|March 11, 2009
Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee modelSaleem Kamili, Vitini Sozzi, Geoff Thompson, et al.
Acta Gastro-Enterologica Belgica|November 23, 2013
Longitudinal observation of viral load changes in untreated HBeAg negative chronic hepatitis BCatherine M N Croagh, Sally J Bell, Robert Y Chen, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitroWilliam E Delaney, Ros Edwards, Danni Colledge, et al.
AIDS (London, England)|July 11, 2003
Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individualsLouise Cooley, Anna Ayres, Angeline Bartholomeusz, et al.
Journal of Medical Virology|September 28, 2010
Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation patternHans Damerow, Lilly Yuen, Johannes Wiegand, et al.
Journal of Virology|July 30, 2003
Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virionsRalf Schilling, Samreen Ijaz, Michail Davidoff, et al.
Gastroenterology|February 8, 2002
Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantationC-Thomas Bock, Hans L Tillmann, Joseph Torresi, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Bulletin of the World Health Organization|April 30, 2010
Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?C John Clements, Ben Coghlan, Mick Creati, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2007
The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitroNadia Warner, Stephen Locarnini, Michael Kuiper, et al.
Antiviral Research|December 6, 2011
Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunitsWan-Shoo Cheong, Michiko Hyakumura, Lilly Yuen, et al.
Hepatology (Baltimore, Md.)|March 11, 2009
Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee modelSaleem Kamili, Vitini Sozzi, Geoff Thompson, et al.
Acta Gastro-Enterologica Belgica|November 23, 2013
Longitudinal observation of viral load changes in untreated HBeAg negative chronic hepatitis BCatherine M N Croagh, Sally J Bell, Robert Y Chen, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitroWilliam E Delaney, Ros Edwards, Danni Colledge, et al.
AIDS (London, England)|July 11, 2003
Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individualsLouise Cooley, Anna Ayres, Angeline Bartholomeusz, et al.
Journal of Medical Virology|September 28, 2010
Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation patternHans Damerow, Lilly Yuen, Johannes Wiegand, et al.
Journal of Virology|July 30, 2003
Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virionsRalf Schilling, Samreen Ijaz, Michail Davidoff, et al.
Gastroenterology|February 8, 2002
Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantationC-Thomas Bock, Hans L Tillmann, Joseph Torresi, et al.
Pageof 14